SANDU PHARMA Fact Sheet, SANDU PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA Fact Sheet    (SNPH)


EV Stocks: Which is Tanushree's Top Pick?


Here is the latest financial fact sheet of SANDU PHARMA. For more details, see the SANDU PHARMA quarterly results and SANDU PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

SANDU PHARMA Price History

Price Rs 45.7
Mkt Cap Rs m 323
Vol '000 2.7
P/E X 19.9
P/CF X 19.6
EPS (TTM) Rs 2.3
% ch % 2.0
No. of shares m 7.08
% ch week % -1.8
% ch 1-mth % -8.2
% ch 12-mth % 44.2
52 week H/L Rs 62.9/27.5
(As on Dec 3, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SANDU PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SANDU PHARMA EQUITY SHARE DATA
High Rs4542402744 
Low Rs2423181012 
Sales per share (Unadj.) Rs59.369.069.868.474.2 
Earnings per share (Unadj.) Rs-0.60.80.91.01.4 
Diluted earnings per shareRs-0.60.80.91.01.5 
Cash flow per share (Unadj.) Rs0.61.61.81.82.1 
Dividends per share (Unadj.) Rs00000.50 
Adj. dividends per shareRs0.000.000.000.000.56 
Avg Dividend yield %00001.8 
Book value per share (Unadj.) Rs38.739.740.741.341.2 
Adj. book value per shareRs38.739.740.741.346.0 
Shares outstanding (eoy) m7.087.087.087.087.92 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.60.50.40.30.4 
Avg P/E ratio x-55.140.730.918.420.0 
P/CF ratio (eoy) x57.919.615.910.413.3 
Price / Book Value ratio x0.90.80.70.50.7 
Dividend payout %000036.3 
Avg Mkt Cap Rs m245229207133219 
No. of employees `000NANANANANA 
Total wages/salary Rs m5459656980 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SANDU PHARMA INCOME DATA
Net Sales Rs m420489494484588 
Other income Rs m51642 
Total revenues Rs m425490500488589 
Gross profit Rs m1925211522 
Depreciation Rs m96666 
Interest Rs m15121041 
Profit before tax Rs m1810917 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m52326 
Profit after tax Rs m-467711 
Gross profit margin %4.65.04.23.23.7 
Effective tax rate %938.825.734.221.635.0 
Net profit margin %-1.11.11.41.51.9 
SANDU PHARMA BALANCE SHEET DATA
Current assets Rs m280208201224305 
Current liabilities Rs m181154139113125 
Net working cap to sales %23.411.212.622.930.7 
Current ratio x1.51.41.42.02.4 
Inventory Days Days94648182 
Debtors Days Days55503535,269,39933,221,694 
Net fixed assets Rs m185237236190164 
Share capital Rs m7171717179 
"Free" reserves Rs m203210217222247 
Net worth Rs m274281288292326 
Long term debt Rs m12200 
Total assets Rs m464445436414470 
Interest coverage x1.01.62.03.115.6 
Debt to equity ratio x00000 
Sales to assets ratio x0.91.11.11.21.3 
Return on assets %2.34.03.92.82.6 
Return on equity %-1.62.02.32.53.4 
Return on capital %5.67.07.04.65.5 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
SANDU PHARMA CASH FLOW
From Operations Rs m 49 12 37 62 76 
From Investments Rs m -6 -6 -1 -4 -56 
From Financial Activity Rs m -23 -19 -43 -54 13 
Net Cashflow Rs m 20 -13 -6 5 33 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 45.0%
Institution 0.0%
Non-Institution 55.0%
Total 100.0%
Free Float 55.0%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No 25 26 29 & 30, Pilerne Industrial Estate, Marra, Bardez - 403511
E-MAIL sandhupharma@sandu.in WEB www.sandu.in
TEL 0832-2407474 / 6715000 FAX 832-2407008
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, L B S Marg, Vikhroli (West)
YEAR OF INC: 1985 BSE CODE: 524703 FV (Rs): 10 DIV YIELD (%): 1.2

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  

Compare SANDU PHARMA With:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  




Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SANDU PHARMA

  • Track your investment in SANDU PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SANDU PHARMA

SANDU PHARMA - JAGSON PHAR COMPARISON

COMPARE SANDU PHARMA WITH

MARKET STATS